Ghazi Kashmolah - 17 Aug 2022 Form 4/A - Amendment Insider Report for Lucira Health, Inc.

Role
Ex VP & Chief Quality Officer
Signature
/s/ Dan George, Attorney-in-Fact for Ghazi Kashmolah
Issuer symbol
N/A
Transactions as of
17 Aug 2022
Net transactions value
-$48,066
Form type
4/A - Amendment
Filing time
24 Aug 2022, 15:54:32 UTC
Date Of Original Report
19 Aug 2022
Previous filing
01 Oct 2021
Next filing
29 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LHDXQ Common Stock Sale $48,066 -19,074 -9.5% $2.52* 180,757 17 Aug 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on September 30, 2021 for 197,240 shares.
F2 This amendment corrects the price of the shares sold, which was inadvertently incorrectly reported on the original Form 4.
F3 Includes 2,591 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on February 20, 2022.